These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17175177)

  • 1. [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region.
    Pinborg LH; Videbaek C; Ziebell M; Mackeprang T; Friberg L; Rasmussen H; Knudsen GM; Glenthoj BY
    Neuroimage; 2007 Feb; 34(4):1450-3. PubMed ID: 17175177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I]epidepride SPECT in humans.
    Varrone A; Fujita M; Verhoeff NP; Zoghbi SS; Baldwin RM; Rajeevan N; Charney DS; Seibyl JP; Innis RB
    J Nucl Med; 2000 Aug; 41(8):1343-51. PubMed ID: 10945525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain.
    de Paulis T
    Curr Pharm Des; 2003; 9(8):673-96. PubMed ID: 12570798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.
    Langer O; Halldin C; Dollé F; Swahn CG; Olsson H; Karlsson P; Hall H; Sandell J; Lundkvist C; Vaufrey F; Loc'h C; Crouzel C; Mazière B; Farde L
    Nucl Med Biol; 1999 Jul; 26(5):509-18. PubMed ID: 10473189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.
    Asselin MC; Montgomery AJ; Grasby PM; Hume SP
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):378-92. PubMed ID: 16736043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study.
    Bigliani V; Mulligan RS; Acton PD; Ohlsen RI; Pike VW; Ell PJ; Gacinovic S; Kerwin RW; Pilowsky LS
    Psychopharmacology (Berl); 2000 Jun; 150(2):132-40. PubMed ID: 10907666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
    Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K
    J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [123I]Epidepride neuroimaging of dopamine D2/D3 receptor in chronic MK-801-induced rat schizophrenia model.
    Huang YR; Shih JM; Chang KW; Huang C; Wu YL; Chen CC
    Nucl Med Biol; 2012 Aug; 39(6):826-32. PubMed ID: 22464847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride.
    Stone JM; Bressan RA; Erlandsson K; Ell PJ; Pilowsky LS
    Psychopharmacology (Berl); 2005 Aug; 180(4):664-9. PubMed ID: 15719226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.
    Pirker W; Asenbaum S; Wenger S; Kornhuber J; Angelberger P; Deecke L; Podreka I; Brücke T
    J Nucl Med; 1997 Nov; 38(11):1711-7. PubMed ID: 9374338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release.
    Narendran R; Mason NS; Chen CM; Himes M; Keating P; May MA; Rabiner EA; Laruelle M; Mathis CA; Frankle WG
    Synapse; 2011 Oct; 65(10):991-7. PubMed ID: 21360596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECT.
    Ichise M; Fujita M; Seibyl JP; Verhoeff NP; Baldwin RM; Zoghbi SS; Rajeevan N; Charney DS; Innis RB
    J Nucl Med; 1999 Nov; 40(11):1902-12. PubMed ID: 10565788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
    Pirker W; Riedl M; Luger A; Czech T; Rössler K; Asenbaum S; Angelberger P; Kornhuber J; Deecke L; Podreka I; Brücke T
    J Nucl Med; 1996 Dec; 37(12):1931-7. PubMed ID: 8970508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of extrastriatal dopamine D2 receptors in the human brain.
    Kessler RM; Mason NS; Votaw JR; De Paulis T; Clanton JA; Ansari MS; Schmidt DE; Manning RG; Bell RL
    Eur J Pharmacol; 1992 Nov; 223(1):105-7. PubMed ID: 1478255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.
    Olsson H; Halldin C; Farde L
    Neuroimage; 2004 Jun; 22(2):794-803. PubMed ID: 15193608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography.
    Almeida P; Ribeiro MJ; Bottlaender M; Loc'h C; Langer O; Strul D; Hugonnard P; Grangeat P; Mazière B; Bendriem B
    Eur J Nucl Med; 1999 Dec; 26(12):1580-8. PubMed ID: 10638410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data.
    Olsson H; Farde L
    Neuroimage; 2001 Oct; 14(4):936-45. PubMed ID: 11554812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.
    Vandehey NT; Moirano JM; Converse AK; Holden JE; Mukherjee J; Murali D; Nickles RJ; Davidson RJ; Schneider ML; Christian BT
    J Cereb Blood Flow Metab; 2010 May; 30(5):994-1007. PubMed ID: 20040928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.